Rouzbeh Chegeni

600 total citations
24 papers, 422 citations indexed

About

Rouzbeh Chegeni is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Rouzbeh Chegeni has authored 24 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Rouzbeh Chegeni's work include Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Rouzbeh Chegeni is often cited by papers focused on Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Rouzbeh Chegeni collaborates with scholars based in Canada, Iran and United States. Rouzbeh Chegeni's co-authors include Majid Safa, Seyed Esmaeil Ahmadi, Bahman Zarandi, David Lillicrap, Braden Waters, Mohammad Qadura, Christine Hough, Erin Burnett, Maha Othman and Andrea Labelle and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Cellular Physiology.

In The Last Decade

Rouzbeh Chegeni

24 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rouzbeh Chegeni Canada 9 220 180 107 74 57 24 422
Vaia Stavropoulou Switzerland 9 212 1.0× 269 1.5× 125 1.2× 76 1.0× 47 0.8× 18 417
Catherine Godon France 11 307 1.4× 348 1.9× 192 1.8× 40 0.5× 105 1.8× 24 556
Sonja Schiffer Germany 11 110 0.5× 151 0.8× 55 0.5× 179 2.4× 63 1.1× 12 473
Danielle N. Yarde United States 8 145 0.7× 232 1.3× 140 1.3× 65 0.9× 25 0.4× 11 386
Hans G. Drexler Germany 9 133 0.6× 180 1.0× 154 1.4× 150 2.0× 92 1.6× 11 485
Isabel Boivin Canada 12 268 1.2× 302 1.7× 68 0.6× 61 0.8× 94 1.6× 20 536
ZY Lu France 6 312 1.4× 248 1.4× 252 2.4× 166 2.2× 34 0.6× 9 552
M J Rapp Canada 8 361 1.6× 202 1.1× 188 1.8× 77 1.0× 115 2.0× 10 459
Edmund C. Lee United States 4 179 0.8× 394 2.2× 171 1.6× 24 0.3× 36 0.6× 4 468
Osama Elbaz Egypt 10 167 0.8× 142 0.8× 105 1.0× 193 2.6× 36 0.6× 17 439

Countries citing papers authored by Rouzbeh Chegeni

Since Specialization
Citations

This map shows the geographic impact of Rouzbeh Chegeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rouzbeh Chegeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rouzbeh Chegeni more than expected).

Fields of papers citing papers by Rouzbeh Chegeni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rouzbeh Chegeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rouzbeh Chegeni. The network helps show where Rouzbeh Chegeni may publish in the future.

Co-authorship network of co-authors of Rouzbeh Chegeni

This figure shows the co-authorship network connecting the top 25 collaborators of Rouzbeh Chegeni. A scholar is included among the top collaborators of Rouzbeh Chegeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rouzbeh Chegeni. Rouzbeh Chegeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chegeni, Rouzbeh, et al.. (2023). Ultrasensitive quantitation of FLT3-ITD mutation in patients with acute myeloid leukemia using ddPCR. Molecular Biology Reports. 50(7). 6097–6105. 2 indexed citations
2.
Chegeni, Rouzbeh, et al.. (2022). Inhibition of Skp2 enhances doxorubicin‐induced cell death in B cell precursor acute lymphoblastic leukemia. Cell Biology International. 46(6). 895–906. 4 indexed citations
3.
Ahmadi, Seyed Esmaeil, et al.. (2021). Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment. Experimental Hematology and Oncology. 10(1). 51–51. 17 indexed citations
4.
Ahmadi, Seyed Esmaeil, et al.. (2021). MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies. Journal of Hematology & Oncology. 14(1). 121–121. 122 indexed citations
5.
Ahmadi, Seyed Esmaeil, et al.. (2021). Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies. Journal of Hematology & Oncology. 14(1). 135–135. 4 indexed citations
6.
Bahrami, Armina Alagheband, Mojgan Bandehpour, Bahram Kazemi, et al.. (2020). Assessment of a poly-epitope candidate vaccine against Hepatitis B, C, and poliovirus in interaction with monocyte-derived dendritic cells: An ex-vivo study. Human Immunology. 81(5). 218–227. 1 indexed citations
7.
Mehravar, Maryam, Elham Roshandel, Maryam Salimi, et al.. (2020). Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies. Immunology Letters. 226. 71–82. 7 indexed citations
8.
Kazemi, Mohammad Hossein, Mehdi Talebi, Rouzbeh Chegeni, et al.. (2020). Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease. Medical Journal of the Islamic Republic of Iran. 34. 151–151. 8 indexed citations
9.
Bandehpour, Mojgan, et al.. (2020). Expression, Purification, and Evaluation of Anti-IL-2Rα Antibody Secreted by Leishmania tarentolae. International Journal of Peptide Research and Therapeutics. 27(1). 301–307. 2 indexed citations
10.
Chegeni, Rouzbeh, et al.. (2020). Altering chromatin methylation patterns and the transcriptional network involved in regulation of hematopoietic stem cell fate. Journal of Cellular Physiology. 235(10). 6404–6423. 4 indexed citations
11.
Chegeni, Rouzbeh, et al.. (2019). Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation. Transfusion and Apheresis Science. 59(2). 102696–102696. 11 indexed citations
12.
Kheirandish, Farnaz, et al.. (2016). THE CYTOTOXIC AND ANTILEISHMANIAL EFFECTS OF SATUREJA KHUZESTANICA ESSENTIAL OIL. SHILAP Revista de lepidopterología. 5 indexed citations
13.
Kaviani, Saeid, Mehrdad Noruzinia, Masoud Soleimani, et al.. (2013). Evaluation of H3 Histone Methylation and Colony Formation in Erythroid Progenitors Treated with Thalidomide and Sodium Butyrate. PubMed. 19(1). 1–5. 14 indexed citations
14.
Qadura, Mohammad, Braden Waters, Erin Burnett, et al.. (2010). Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice. Haemophilia. 17(2). 288–295. 34 indexed citations
15.
Chegeni, Rouzbeh, Linda M. Vickars, Emmanuel J. Favaloro, David Lillicrap, & Maha Othman. (2010). Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease. Thrombosis Research. 127(2). 161–166. 4 indexed citations
16.
Qadura, Mohammad, Braden Waters, Erin Burnett, et al.. (2009). Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice. Blood. 114(4). 871–880. 46 indexed citations
17.
Qadura, Mohammad, Maha Othman, Braden Waters, et al.. (2008). Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells. Journal of Thrombosis and Haemostasis. 6(12). 2095–2104. 33 indexed citations
18.
19.
Chegeni, Rouzbeh, et al.. (2006). Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis. Thrombosis Research. 119(2). 189–193. 5 indexed citations
20.
Chegeni, Rouzbeh, et al.. (2004). Detection of the Factor V Leiden Mutation in Iranian Patients with Venous Thrombosis. Biotechnology(Faisalabad). 4(1). 76–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vaia Stavropoulou Breakdown of academic impact, for papers by Catherine Godon Breakdown of academic impact, for papers by Sonja Schiffer Breakdown of academic impact, for papers by Danielle N. Yarde Breakdown of academic impact, for papers by Hans G. Drexler Breakdown of academic impact, for papers by Isabel Boivin Breakdown of academic impact, for papers by ZY Lu Breakdown of academic impact, for papers by M J Rapp Breakdown of academic impact, for papers by Edmund C. Lee Breakdown of academic impact, for papers by Osama Elbaz
Rankless by CCL
2026